Terms: = Ovarian cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Clinical Outcome
1 results:
1. A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy.
Darcy KM; Tian C; Reed E
Cancer Res; 2007 May; 67(9):4474-81. PubMed ID: 17483363
[TBL] [Abstract] [Full Text] [Related]
